1925–2025: A Century of International Pharmaceutical Law
Riboulet-Zemouli, K. (2025) “1925–2025: A Century of International Pharmaceutical Law” Journal of Pharmaceutical Policy and Practice, 2025
Cannabis for Medical Purposes: Non-discriminatory access E/CN.7/2024/NGO/2 (with MAPS & IACM Patients Council)
Cannabis for Medical Purposes: Non-discriminatory access E/CN.7/2024/NGO/2 (with MAPS & IACM Patients Council)![[PDF] Le cannabis médical, déconfiné et déclassifié : retour sur le récent changement de classification internationale](https://i0.wp.com/kenzi.zemou.li/wp-content/uploads/2022/08/psychotropes-28-1-couverture.png?resize=772%2C494&ssl=1)
[PDF] Le cannabis médical, déconfiné et déclassifié : retour sur le récent changement de classification internationale
Accès PDF pour l’article : Riboulet-Zemouli, Kenzi. Psychotropes, vol. 28, no. 1, 2022, pp. 71-104. DOI: 10.3917/psyt.281.0071
Cannabis amnesia – Indian hemp parley at the Office International d’Hygiène Publique in 1935 (preprint)
Authorea Preprints. DOI: 10.22541/au.165237542.24089054/v1
![INCB [Medical] Cannabis Control Initiative Questionnaire for Civil Society – Inputs and suggestions by FAAAT think & do tank](https://i0.wp.com/kenzi.zemou.li/wp-content/uploads/2021/06/INCBMAP.png?resize=689%2C404&ssl=1)
INCB [Medical] Cannabis Control Initiative Questionnaire for Civil Society – Inputs and suggestions by FAAAT think & do tank
Answers to 2022 INCB questionnaire on reporting requirements for medical cannabis
![[PDF] WHO’s first scientific review of medicinal Cannabis: from global struggle to patient implications](https://i0.wp.com/kenzi.zemou.li/wp-content/uploads/2022/03/DHS-paper-cover-KRZ-MK-2022.png?resize=682%2C503&ssl=1)
[PDF] WHO’s first scientific review of medicinal Cannabis: from global struggle to patient implications
Full PDF access for the article as published in Drugs, Habits and Social Policy, 2022; 23(1): 5-21. DOI: 10.1108/DHS-11-2021-006